Asset Details
Do you wish to reserve the book?
High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
Do you wish to request the book?
High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
2020
Overview
BACKGROUNDPatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) differ in the severity of disease. We hypothesized that characteristics of SARS-CoV-2-specific immunity correlate with disease severity.METHODSIn this study, SARS-CoV-2-specific T cells and antibodies were characterized in uninfected controls and patients with different coronavirus disease 2019 (COVID-19) disease severity. SARS-CoV-2-specific T cells were flow cytometrically quantified after stimulation with SARS-CoV-2 peptide pools and analyzed for expression of cytokines (IFN-γ, IL-2, and TNF-α) and markers for activation, proliferation, and functional anergy. SARS-CoV-2-specific IgG and IgA antibodies were quantified using ELISA. Moreover, global characteristics of lymphocyte subpopulations were compared between patient groups and uninfected controls.RESULTSDespite severe lymphopenia affecting all major lymphocyte subpopulations, patients with severe disease mounted significantly higher levels of SARS-CoV-2-specific T cells as compared with convalescent individuals. SARS-CoV-2-specific CD4+ T cells dominated over CD8+ T cells and closely correlated with the number of plasmablasts and SARS-CoV-2-specific IgA and IgG levels. Unlike in convalescent patients, SARS-CoV-2-specific T cells in patients with severe disease showed marked alterations in phenotypical and functional properties, which also extended to CD4+ and CD8+ T cells in general.CONCLUSIONGiven the strong induction of specific immunity to control viral replication in patients with severe disease, the functionally altered characteristics may result from the need for contraction of specific and general immunity to counteract excessive immunopathology in the lung.FUNDINGThe study was supported by institutional funds to MS and in part by grants of Saarland University, the State of Saarland, and the Rolf M. Schwiete Stiftung.
Publisher
American Society for Clinical Investigation,American Society for Clinical investigation
Subject
/ Anergy
/ Antibodies, Viral - classification
/ Antigens
/ Betacoronavirus - immunology
/ Betacoronavirus - isolation & purification
/ Blood
/ Cardiovascular Diseases - epidemiology
/ Cells
/ Coronavirus Infections - blood
/ Coronavirus Infections - epidemiology
/ Coronavirus Infections - physiopathology
/ Coronavirus Infections - virology
/ COVID-19
/ Critical Care - statistics & numerical data
/ Disease
/ Enzyme-linked immunosorbent assay
/ Female
/ Humans
/ Immunity
/ Leukocyte Count - statistics & numerical data
/ Lymphocyte Subsets - classification
/ Male
/ Metabolic Diseases - epidemiology
/ Patients
/ Peptides
/ Pneumonia, Viral - epidemiology
/ Pneumonia, Viral - physiopathology
/ Proteins
/ Severe acute respiratory syndrome coronavirus 2
